George L. Sing, Director at REGENERON PHARMACEUTICALS INC (REGN), sold 15,000 shares at $423.12 ($6.3M) on 2015-02-20, disclosed to the SEC on 2015-02-24.
Open-market sale of $6.3M REGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| REGN | SELL | 2024-02-12 | $950K | — | Filing → |
| REGN | SELL | 2022-03-01 | $2.5M | — | Filing → |
| REGN | SELL | 2021-11-23 | $2.0M | — | Filing → |